STING1 and melanoma: In murine melanoma models, we have previously shown that STING agonist ADU-S100 promotes vascular normalization (VN), as demonstrated by increased vascular perfusion, enhanced pericyte coverage of blood vessels, development of high endothelial venules (HEV) and lymphangiogenesis in treated tumors (10).